{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:39:45Z","timestamp":1788813585907,"version":"build-2803163510"},"reference-count":15,"publisher":"Baishideng Publishing Group Inc.","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Gastrointest Oncol"],"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies with limited treatment efficacy. Advances in precision oncology, enabled by next-generation sequencing, have highlighted key molecular targets. Kirsten rat sarcoma viral oncogene homolog mutations, present in up to 90% of cases, drive aggressive biology, though most variants remain undruggable; allele-specific inhibitors and exosome-based RNA interference are under exploration. Breast cancer susceptibility gene 1\/2 mutations occur in 4%-7% of patients, conferring sensitivity to platinum agents and poly(ADP-ribose) polymerase inhibitors. Other rare but actionable alterations - such as v-raf murine sarcoma viral oncogene homolog B1 (V600), neurotrophic tyrosine receptor kinase, fibroblast growth factor receptor 2, and RET fusions - show benefit in tumor-agnostic trials, broadening options for selected subgroups. Immunotherapy is limited, as high tumor mutational burden and mismatch repair deficiency are uncommon in PDAC, though predictive when present. Co-mutations in tumor protein p53, cyclin-dependent kinase inhibitor 2A, and SMAD4 further stratify prognosis and influence therapy response. Cross-cancer analyses underscore the necessity of PDAC-specific strategies despite shared genomic drivers. Collectively, these insights support routine germline and somatic testing, enrollment in biomarker-matched trials, and rational combination strategies, establishing molecular profiling as central to advancing precision treatment in pancreatic cancer.<\/jats:p>","DOI":"10.4251\/wjgo.v17.i11.111264","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T05:42:27Z","timestamp":1762926147000},"source":"Crossref","is-referenced-by-count":1,"title":["Precision medicine advances in pancreatic cancer driven by genomic and molecular alterations"],"prefix":"10.4251","volume":"17","author":[{"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00261-2"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2021.06.008"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.11150"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-022-00334-z"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.53588"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.PANCA2023-C098"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature22341"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.418"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2728"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1517\/17425240903544462"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0275"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgae066"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/PO.23.00092"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-2545"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.114088"}],"container-title":["World Journal of Gastrointestinal Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1948-5204\/full\/v17\/i11\/111264.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1948-5204\/full\/v17\/i11\/111264.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T05:43:58Z","timestamp":1762926238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1948-5204\/full\/v17\/i11\/111264.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":15,"journal-issue":{"issue":"11"},"alternative-id":["111264"],"URL":"https:\/\/doi.org\/10.4251\/wjgo.v17.i11.111264","relation":{},"ISSN":["1948-5204"],"issn-type":[{"value":"1948-5204","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,15]]}}}